• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    China Medical Second Opinion Market

    ID: MRFR/HC/42244-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    China Medical Second Opinion Market Research Report By Application Outlook (Cancer, Diabetes, Cardiac Disorders, Neurological Disorders, Respiratory Disorders, Ocular Disorders), By Source of Service Outlook (In-House, Outsourced), By Services Outlook (Medical Condition Management, Post-Acute Care Nursing, Medical Peer Review Services) and By Type Outlook (Hospitals Physicians/Specialties, Online Physicians Portal, Medical Second Opinion Companies, Health Insurance Companies) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    China Medical Second Opinion Market Research Report — Forecast till 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    China Medical Second Opinion Market Summary

    The China Medical Device Second Opinion market is projected to grow significantly from 0.42 USD Billion in 2024 to 1.83 USD Billion by 2035.

    Key Market Trends & Highlights

    China Medical Device Second Opinion Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate (CAGR) of 14.32% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 1.83 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 0.42 USD Billion, reflecting the current demand for second opinion services in medical devices.
    • Growing adoption of telemedicine due to increasing patient awareness is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.42 (USD Billion)
    2035 Market Size 1.83 (USD Billion)
    CAGR (2025-2035) 14.32%

    Major Players

    Medtronic, Mindray, Philips, Boston Scientific, Johnson and Johnson, Siemens Healthineers, Hologic, Terumo, Canon Medical Systems, B.Braun, Fujifilm, GE Healthcare, Abbott Laboratories, Stryker, Olympus

    China Medical Second Opinion Market Trends

    The growing middle class in China is becoming more health-conscious and willing to invest in high-quality medical care, prompting a rise in demand for second opinions from reputable medical professionals.Additionally, regulatory agencies are implementing reforms aimed at improving the quality and transparency of medical devices. 

    The National Medical Products Administration (NMPA) in China is enhancing its review processes, leading to increased trust among patients regarding the reliability of medical devices. As patients become more informed, they are also leveraging digital platforms to obtain second opinions, which creates an opportunity for the market to expand through online health services. Recent trends also indicate a rise in collaboration between domestic and international medical institutions, fostering knowledge exchange and improving patient outcomes.This collaboration opens doors for more robust second opinion services tailored to the unique demands of the Chinese population.

    Furthermore, the COVID-19 pandemic has accelerated the adoption of digital health tools, making remote consultations more acceptable. As these tools and platforms continue to evolve, they will likely play a crucial role in shaping the landscape of the medical device second opinion market in China.

    Market Segment Insights

    Medical Device Second Opinion Market Application Outlook Insights

    The Application Outlook segment of the China Medical Device Second Opinion Market provides a comprehensive view of how different medical conditions are addressed using advanced diagnostic technologies. In China, the increasing prevalence of conditions such as Cancer and Diabetes is notably impacting the demand for second opinions, as patients seek confirmation of diagnoses and treatment plans from multiple healthcare professionals to ensure best practices. Cancer, being a leading cause of mortality in the region, has prompted a significant push towards enhanced diagnostic capabilities, facilitating timely and accurate interventions.

    Similarly, the rising incidence of Diabetes is fueling interest in devices that allow for precise monitoring and management of blood sugar levels, contributing to the market’s expansion. 

    Cardiac Valve Disorders, which account for a large portion of healthcare expenditure, likewise underscore the importance of obtaining second opinions to verify complex treatment approaches, especially given the intricacies involved in cardiovascular health. Neurological Disorders, including conditions like stroke and neurodegenerative diseases, require highly specialized inputs, making a second opinion critical in determining the most effective treatment pathways. As respiratory diseases such as COPD and asthma continue to rise, there is an urgent need for devices that support accurate assessments and tailored interventions, making the second opinion process integral to patient care in this domain. 

    Finally, Ocular Disorders are gaining attention as advancements in ophthalmic medical devices create opportunities for second opinions regarding surgeries and therapies, ensuring that patients receive optimal care for their visual health. Overall, the insights gathered from the Application Outlook segment indicate a clear trend toward collaboration and thorough diagnostic evaluation within the China Medical Device Second Opinion Market, enhancing patient safety and treatment efficacy. This market development is informed by both demographic changes and the collective goal of improving healthcare outcomes in the nation.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Medical Device Second Opinion Market Source of Service Outlook Insights

    The Source of Service Outlook segment in the China Medical Device Second Opinion Market showcases diverse avenues for delivering essential healthcare insights. The increasing complexity of medical devices and treatment pathways has led to a growing reliance on obtaining second opinions, reinforcing the importance of this sector within the healthcare landscape. The In-House segment, which primarily focuses on leveraging internal capabilities, often ensures faster communication and collaboration among healthcare teams, thereby enhancing the quality of patient care.Conversely, the Outsourced segment offers specialized expertise and access to advanced technologies, which can significantly improve diagnostic accuracy and treatment options for patients. 

    In recent trends, the increasing push towards telemedicine and digital health services in China has elevated the Outsourced model's status, making it a favored choice among many healthcare providers seeking comprehensive analyses and consultations. The continued advancements in technology and shared best practices within both segments are anticipated to significantly drive the future growth of the China Medical Device Second Opinion Market, responding effectively to rising patient demands and the need for high-quality medical assessments.

    Medical Device Second Opinion Market Services Outlook Insights

    The Services Outlook segment of the China Medical Device Second Opinion Market encompasses various crucial areas focused on enhancing patient care and outcomes. Medical Condition Management is significant as it helps patients navigate complex health issues, ensuring they receive personalized recommendations and treatment plans that align with their specific conditions.

    Post-Acute Care Nursing plays an essential role by facilitating a smooth transition for patients recovering after hospitalization, thereby minimizing the risk of readmission and improving overall rehabilitation success rates.Medical Peer Review Services contribute to the credibility and reliability of diagnoses and treatments, fostering a culture of collaboration among healthcare professionals that ultimately benefits patient care. 

    The overall growth of this segment is driven by an increasing demand for high-quality healthcare services, the advancement of medical technologies, and the in-depth analysis of patient data to guide treatment choices. Moreover, the emphasis on patient-centered approaches in China's healthcare system indicates that services focusing on these areas will be more integral in the coming years, reflecting ongoing improvements throughout the industry.

    Medical Device Second Opinion Market Type Outlook Insights

    The China Medical Device Second Opinion Market, recognized for its potential growth, presents a diverse Type Outlook that captures various critical segments such as Hospitals Physicians/ , Online Physicians Portal, Medical Second Opinion Companies, and Health Insurance Companies. Hospitals and specialty physicians play a vital role in providing personalized consultations, which has become essential for patient reassurance in complicated medical scenarios, fostering a more comprehensive understanding of complex medical conditions. Online Physicians Portals have grown in prominence, driven by the increasing demand for convenient healthcare access, significantly enhancing patient accessibility to expert opinions in real-time.

    Medical Second Opinion Companies cater to a growing awareness of the need for additional insights, helping patients to make informed decisions regarding their treatment paths. Health Insurance Companies are increasingly involved in facilitating second opinions, recognizing it as a means to enhance patient care while potentially lowering healthcare costs. This multi-faceted outlook reflects a vibrant synergy in the market, where each segment plays a pivotal role in shaping patient outcomes, ultimately leading to the development of a robust healthcare ecosystem in China.

    Get more detailed insights about China Medical Second Opinion Market Research Report — Forecast till 2035

    Key Players and Competitive Insights

    The China Medical Device Second Opinion Market has shown significant growth and development over recent years, driven by various factors including the increasing demand for advanced healthcare solutions, a growing aging population, and rising investments in healthcare infrastructure. The competitive landscape is characterized by both local and international companies striving to establish their presence in this lucrative market. The emphasis on ensuring quality healthcare and improving patient outcomes has led to a surge in the adoption of innovative technologies and devices, enhancing the capabilities of healthcare professionals to make informed decisions. 

    This market is not only focused on providing medical devices but also emphasizes the importance of accurate second opinions to avoid misdiagnoses and optimize treatment pathways, leading to improved health services overall. One of the key players within the China Medical Device Second Opinion Market is Medtronic, a globally recognized leader in medical technology. In China, Medtronic has made significant inroads by aligning its product offerings with local healthcare needs and regulations, securing a strong foothold in the rapidly evolving market. Medtronic is known for its diverse portfolio, which includes advanced cardiovascular devices, diabetes management products, and surgical technologies.

    Its strengths lie in robust research and development capabilities, extensive distribution networks, and strategic collaborations with local healthcare institutions. 

    These strengths not only reinforce Medtronic's reputation but also enhance its ability to meet the increasing demands for quality medical interventions and second medical opinions in China.Mindray is another prominent player in the China Medical Device Second Opinion Market, renowned for its innovative medical devices and solutions tailored to meet the needs of healthcare providers. The company specializes in areas such as patient monitoring, in-vitro diagnostics, and ultrasound equipment, which are critical in providing comprehensive and precise medical evaluations. Mindray's strong market presence is bolstered by its commitment to quality, affordability, and accessibility. 

    The company has undertaken several mergers and acquisitions to expand its product range and enhance technological capabilities, further solidifying its position in the market. With a focus on delivering reliable healthcare solutions, Mindray caters to a wide network of hospitals and clinics across China, addressing the essential need for second opinions and ensuring that patients receive accurate diagnoses and appropriate treatments. As a domestic leader, Mindray significantly contributes to improving healthcare standards and fostering innovation within the Chinese medical sector.

    Key Companies in the China Medical Second Opinion Market market include

    Industry Developments

    Recent developments in the China Medical Device Second Opinion Market reflect a growing emphasis on advanced healthcare technologies and patient-centric solutions. In September 2023, Medtronic announced its collaboration with local Chinese healthcare providers to enhance telehealth services, aiming to streamline second opinions for complex medical procedures. Mindray has reported significant growth in market share, bolstered by innovative diagnostic devices that facilitate efficient consultations between patients and specialists. In October 2023, Siemens Healthineers launched a digital platform in China designed for remote second-opinion consultations, emphasizing accessibility and quality healthcare.

    Meanwhile, Boston Scientific has expanded its product portfolio in China, focusing on minimally invasive technologies that are increasingly being recommended through second opinions as healthcare providers seek the best outcomes for patients. Notably, October 2022 witnessed Johnson & Johnson's acquisition of a major Chinese medical device firm, enhancing its capabilities in the local market. Growth in key companies like GE Healthcare and Philips is also notable as they adapt to China's regulatory landscape, increasingly integrating AI to assist in the second opinion process. The market remains dynamic as firms respond to an evolving healthcare environment focused on quality and innovation.

    Market Segmentation

    Type Outlook

    • Hospitals Physicians/Specialties
    • Online Physicians Portal
    • Medical Second Opinion Companies
    • Health Insurance Companies

    Services Outlook

    • Medical Condition Management
    • Post-Acute Care Nursing
    • Medical Peer Review Services

    Application Outlook

    • Cancer
    • Diabetes
    • Cardiac Disorders
    • Neurological Disorders
    • Respiratory Disorders
    • Ocular Disorders

    Medical Device Second Opinion MarketType Outlook

    • Hospitals Physicians/Specialties
    • Online Physicians Portal
    • Medical Second Opinion Companies
    • Health Insurance Companies

    Medical Device Second Opinion Market Services Outlook

    • Medical Condition Management
    • Post-Acute Care Nursing
    • Medical Peer Review Services

    Medical Device Second Opinion Market Application Outlook

    • Cancer
    • Diabetes
    • Cardiac Disorders
    • Neurological Disorders
    • Respiratory Disorders
    • Ocular Disorders

    Medical Device Second Opinion Market Type Outlook Insights

    • Medtronic
    • Mindray
    • Philips
    • Boston Scientific
    • Johnson and Johnson
    • Siemens Healthineers
    • Hologic
    • Terumo
    • Canon Medical Systems
    • B.Braun
    • Fujifilm
    • GE Healthcare
    • Abbott Laboratories
    • Stryker
    • Olympus

    Medical Device Second Opinion Market Services Outlook Insights

    Medical Device Second Opinion Market Source of Service Outlook

    • In-House
    • Outsourced

    Medical Device Second Opinion Market Application Outlook Insights

    Medical Device Second Opinion Market Source of Service Outlook Insights

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 0.37(USD Billion)
    MARKET SIZE 2024 0.42(USD Billion)
    MARKET SIZE 2035 1.83(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 14.31% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Medtronic, Mindray, Philips, Boston Scientific, Johnson and Johnson, Siemens Healthineers, Hologic, Terumo, Canon Medical Systems, B.Braun, Fujifilm, GE Healthcare, Abbott Laboratories, Stryker, Olympus
    SEGMENTS COVERED Application Outlook, Source of Service Outlook, Services Outlook, Type Outlook
    KEY MARKET OPPORTUNITIES Telehealth integration, Rising chronic diseases, Increasing healthcare insurance, Advanced diagnostics technology, Growing demand for transparency
    KEY MARKET DYNAMICS growing healthcare expenditure, increasing telemedicine adoption, rising patient awareness, regulatory reforms, expanding elderly population
    COUNTRIES COVERED China

    FAQs

    What was the expected market size of the China Medical Second Opinion Market in 2024?

    The China Medical Second Opinion Market was expected to be valued at 0.42 USD Billion in 2024.

    What market value is projected for the China Medical Second Opinion Market by 2035?

    By 2035, the market is projected to reach a value of 1.83 USD Billion.

    What is the expected compound annual growth rate (CAGR) for the market from 2025 to 2035?

    The expected CAGR for the China Medical Second Opinion Market from 2025 to 2035 is 14.31%.

    Which application is forecasted to have the highest market value in 2035?

    The Cancer segment is forecasted to have the highest market value of 0.52 USD Billion in 2035.

    What was the anticipated market value for the Diabetes segment in 2024?

    The Diabetes segment was anticipated to be valued at 0.09 USD Billion in 2024.

    Who are the key players in the China Medical Second Opinion Market?

    Key players in the market include Medtronic, Mindray, Philips, and Boston Scientific among others.

    What will be the market value of the Cardiac Disorders segment by 2035?

    The market value for the Cardiac Disorders segment is expected to reach 0.42 USD Billion by 2035.

    How much is the market for Neurological Disorders expected to grow by 2035?

    The market for Neurological Disorders is expected to grow to 0.27 USD Billion by 2035.

    What was the projected market value for Respiratory Disorders in 2024?

    In 2024, the projected market value for Respiratory Disorders was 0.05 USD Billion.

    What is a significant growth driver for the China Medical Second Opinion Market?

    The increasing prevalence of chronic diseases is a significant growth driver for the market.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials